Omega 3 Fatty Acid Trial

Completed · Phase 1 · Has a placebo group

Conditions studied: Omega-3 Fatty Acids, Pediatric Bipolar Disorder, Adolescent Bipolar Disorder, Magnetic Resonance Spectroscopy Imaging

In brief

This study is being done to detect the metabolic changes that Omega 3 fatty acid treatment has on the brain and to find out whether magnetic resonance spectroscopy (MRS) scan can detect metabolic differences between bipolar patients and healthy control participants.

Key facts

Study ID

NCT00586222

Run by

Mayo Clinic

People needed

19

Starts

2007-01-01

Expected to finish

2010-03-01

Last updated by the study team

2012-01-25

Who can join

Age: 12 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 12 to 18 years old
• both male and female
• all ethnic backgrounds
• DSM-IV criteria for Bipolar Disorder without catatonic and psychotic features or other psychiatric comorbidity, except ADHD

You may not qualify if…

• cardiac pacemakers
• metallic clips
• other bodily metallic implants
• dental braces
• not fluent in English

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.